We are live on ! Find out more
GSEP

Golden State Equity Partners Portfolio holdings

AUM $37.1M
1-Year Est. Return 20.75%
This Fund
S&P 500
This Quarter Est. Return
-1.84%
1 Year Est. Return
+20.75%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$199M
AUM Growth
+$710K
Cap. Flow
+$6.98M
Cap. Flow %
3.51%
Top 10 Hldgs %
25.75%
Holding
224
New
50
Increased
75
Reduced
53
Closed
30

Top Buys

Rank Stock Value
1
FNX icon
First Trust Mid Cap Core AlphaDEX Fund
FNX
+$2.52M
2
SPYG icon
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
+$2.03M
3
MDT icon
Medtronic
MDT
+$1.88M
4
CSX icon
CSX Corp
CSX
+$1.56M
5
SPGM icon
State Street SPDR Portfolio MSCI Global Stock Market ETF
SPGM
+$1.48M

Top Sells

Rank Stock Value
1
AGGY icon
WisdomTree Yield Enhanced US Aggregate Bond Fund
AGGY
+$5.13M
2
HTRB icon
Hartford Total Return Bond ETF
HTRB
+$4.97M
3
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$4.3M
4
TOTL icon
State Street DoubleLine Total Return Tactical ETF
TOTL
+$3.46M
5
FIXD icon
First Trust Smith Opportunistic Fixed Income ETF
FIXD
+$3.45M

Sector Composition

Rank Sector Weight
1 Technology 14.1%
2 Healthcare 10.25%
3 Financials 8.87%
4 Industrials 7.24%
5 Communication Services 4.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VWO icon
176
Vanguard FTSE Emerging Markets ETF
VWO
$124B
$209K 0.11%
4,537
+40
+0.9% +$1.92K
LIN icon
177
Linde
LIN
$226B
$205K 0.1%
641
-3
-0.5% -$928
AMT icon
178
American Tower
AMT
$80.4B
$202K 0.1%
806
+53
+7% +$12.9K
PEP icon
179
PepsiCo
PEP
$190B
$202K 0.1%
1,209
-3
-0.2% -$504
PDBC icon
180
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$6.3B
$197K 0.1%
+11,179
New +$180K
BCRX icon
181
BioCryst Pharmaceuticals
BCRX
$2.4B
$186K 0.09%
11,435
– –
MCA
182
DELISTED
BLACKROCK MUNIYIELD CALIFORNIA QUALITY FUND, INC
MCA
$158K 0.08%
12,000
– –
CBAY
183
DELISTED
Cymabay Therapeutics
CBAY
$157K 0.08%
50,600
+100
+0.2% +$315
ZYME icon
184
Zymeworks
ZYME
$1.73B
$151K 0.08%
23,043
+5,250
+30% +$46.8K
CNTA
185
DELISTED
Centessa Pharmaceuticals
CNTA
$143K 0.07%
15,970
+2,100
+15% +$19.1K
LRMR icon
186
Larimar Therapeutics
LRMR
$432M
$123K 0.06%
30,415
+5,400
+22% +$35.3K
CLSD
187
DELISTED
Clearside Biomedical
CLSD
$72K 0.04%
2,088
+53
+3% +$1.59K
AUTL
188
Autolus Therapeutics
AUTL
$562M
$44K 0.02%
10,555
+50
+0.5% +$210
BNGO icon
189
Bionano Genomics
BNGO
$13.3M
$44K 0.02%
28
+8
+40% +$10.8K
TLIS
190
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
$31K 0.02%
1,476
– –
CKPT
191
DELISTED
Checkpoint Therapeutics
CKPT
$24K 0.01%
1,335
+25
+2% +$537
MREO
192
Mereo BioPharma
MREO
$47.3M
$23K 0.01%
20,300
– –
CYPH
193
Cypherpunk Technologies Inc
CYPH
$73.3M
$20K 0.01%
1,165
– –
ORTX
194
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$16K 0.01%
2,255
+110
+5% +$1.08K
AES icon
195
AES
AES
$10.5B
– –
-26,362
Closed -$641K
ALK icon
196
Alaska Air
ALK
$5.58B
– –
-4,837
Closed -$252K
BYD icon
197
Boyd Gaming
BYD
$6.06B
– –
-4,931
Closed -$323K
CBOE icon
198
Cboe Global Markets
CBOE
$29.9B
– –
-5,009
Closed -$653K
CCL icon
199
Carnival Corporation Ltd
CCL
$39.7B
– –
-15,804
Closed -$318K
CDNS icon
200
Cadence Design Systems
CDNS
$93.4B
– –
-2,020
Closed -$376K
5 6 7
8
9

Similar funds

CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
GC
Gullane Capital Memphis, Tennessee $37.4M AUM 112.18% 1-Year Est. Return
RH
Riverstone Holdings New York $36.9M AUM 80.85% 1-Year Est. Return
ICP
ION Crossover Partners Herzliya Pituach, Israel $36.9M AUM
BAM
BLKBRD Asset Management Old Greenwich, Connecticut $38.3M AUM 34.49% 1-Year Est. Return
CM
CoinFund Management New York $35.4M AUM
VMC
Vanguard Marketing Corp Malvern, Pennsylvania $39.1M AUM
AP
Atairos Partners Bryn Mawr, Pennsylvania $35.2M AUM 32.88% 1-Year Est. Return

Golden State Equity Partners's Q1 2022 Portfolio in Review

As of Q1 2022, Golden State Equity Partners held 224 positions worth $199M, up 0.36% from $198M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Golden State Equity Partners deployed $6.98M of net new capital in Q1 2022, opening 50 new positions and adding to 75 existing holdings. Its largest new stake was Medtronic: 17,756 shares worth $1.97M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was WisdomTree Yield Enhanced US Aggregate Bond Fund, an estimated $5.13M trimmed.

  • Golden State Equity Partners's largest Q1 2022 buy was Medtronic: 17,756 shares worth $1.97M.
  • Golden State Equity Partners added most to First Trust Mid Cap Core AlphaDEX Fund in Q1 2022, an estimated $2.52M increase.
  • Golden State Equity Partners's biggest Q1 2022 reduction was WisdomTree Yield Enhanced US Aggregate Bond Fund, cutting an estimated $5.13M.
  • Golden State Equity Partners fully exited iShares 20+ Year Treasury Bond ETF in Q1 2022, selling an estimated $4.3M.
  • Golden State Equity Partners's ten largest holdings make up 26% of its $199M portfolio in Q1 2022.
  • Golden State Equity Partners opened 50 new positions and closed 30 in Q1 2022.
  • Golden State Equity Partners's portfolio value rose 0.36% quarter-over-quarter to $199M.

Based on Golden State Equity Partners's 13F filing for Q1 2022, filed 16 May 2022.